Identification tag
    1.
    发明授权

    公开(公告)号:US07307537B2

    公开(公告)日:2007-12-11

    申请号:US10496666

    申请日:2002-11-27

    IPC分类号: G08B23/00

    摘要: The invention relates to an identification chip for insertion in an object located in a liquid. The identification chip comprises an acoustic resonator (100), which exhibits a number of distinct resonant frequencies, where the combination of resonant frequencies is unique to the identification chip. This enables the identification chip to be identified by exposing it to an acoustic polling signal, measuring an acoustic response signal and analysing the frequency of the response signal. The resonator (100) comprises a cavity-forming part (110, 120) and a membrane (130). The acoustic resonant frequencies are determined by at least one cavity (140), which is enclosed by the cavity-forming part (110, 120) and the membrane (140). The identification chip can be implanted in a fish, with the object of identifying the fish when it is located in water.

    Identification tag
    2.
    发明申请
    Identification tag 失效
    识别标签

    公开(公告)号:US20070063852A1

    公开(公告)日:2007-03-22

    申请号:US10496666

    申请日:2002-11-27

    IPC分类号: G08B23/00

    摘要: The invention relates to an identification chip for insertion in an object located in a liquid. The identification chip comprises an acoustic resonator (100), which exhibits a number of distinct resonant frequencies, where the combination of resonant frequencies is unique to the identification chip. This enables the identification chip to be identified by exposing it to an acoustic polling signal, measuring an acoustic response signal and analysing the frequency of the response signal. The resonator (100) comprises a cavity-forming part (110, 120) and a membrane (130). The acoustic resonant frequencies are determined by at least one cavity (140), which is enclosed by the cavity-forming part (110, 120) and the membrane (140). The identification chip can be implanted in a fish, with the object of identifying the fish when it is located in water.

    摘要翻译: 本发明涉及一种用于插入位于液体中的物体中的识别芯片。 识别芯片包括声谐振器(100),其表现出许多不同的谐振频率,其中谐振频率的组合对于识别芯片是唯一的。 这使得能够通过将识别芯片暴露于声轮询信号,测量声响应信号和分析响应信号的频率来识别识别芯片。 谐振器(100)包括空腔形成部分(110,120)和膜(130)。 声学共振频率由至少一个由空腔形成部分(110,120)和膜(140)包围的空腔(140)确定。 识别芯片可以植入鱼中,其目的是在鱼类位于水中时识别鱼。

    Method
    3.
    发明申请
    Method 审中-公开
    方法

    公开(公告)号:US20070066893A1

    公开(公告)日:2007-03-22

    申请号:US10558597

    申请日:2004-12-03

    IPC分类号: A61B6/00

    摘要: The present invention relates to a method of processing ultrasound images from a subject preadministered with an ultrasound contrast agent wherein quantitative measures of the contrast enhancement pattern of said lymph nodes are generated. The lymphatic system is made of vessels or ducts that begin in tissues and are designed to carry lymph fluid to local lymph nodes where the fluid is filtered and processed and sent to the next lymph node down the line until the fluid reaches the thoracic duct where it enters the blood stream. Lymph fluid which enters the lymph vessels carries with it substances and materials from the tissue, e.g. antigens, particles and cells. The lymph nodes process the lymph fluid by sieving it and macrophages inside the nodes remove particulate and cell material carried by the lymph fluid via phagocytosis.

    摘要翻译: 本发明涉及一种处理来自预先给予超声造影剂的受试者的超声图像的方法,其中产生所述淋巴结的对比度增强模式的定量测量。 淋巴系统由在组织中开始并被设计成将淋巴液携带到淋巴结的淋巴管构成,其中流体被过滤和处理,并被送到下一个淋巴结,直到流体到达胸廓管 进入血液流。 进入淋巴管的淋巴液携带来自组织的物质和物质,例如, 抗原,颗粒和细胞。 淋巴结通过筛选淋巴液和淋巴结内的巨噬细胞通过吞噬除去淋巴液携带的颗粒和细胞物质。

    Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent
    4.
    发明授权
    Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent 有权
    超声成像通过脉冲能量破坏造影剂组织灌注

    公开(公告)号:US06315730B1

    公开(公告)日:2001-11-13

    申请号:US09425290

    申请日:1999-10-25

    IPC分类号: A61B814

    摘要: A method of measuring tissue perfusion in a human or non-human animal subject which comprises administering an effective amount of an ultrasound contrast agent to said subject, irradiating tissue in a target region with at least one pulse of ultrasound having energy sufficient to destroy or discernibly modify the echogenic properties of substantially all contrast agent in said target region, and ultrasonically detecting and quantifying the rate of flow of either further contrast agent into said target region or modified contrast agent out of said target region.

    摘要翻译: 一种测量人或非人类动物受试者中的组织灌注的方法,其包括向所述受试者施用有效量的超声造影剂,用至少一个具有足以破坏或可辨别的能量的超声波照射目标区域中的组织 修改所述目标区域中基本上所有造影剂的回声特性,并且超声检测和定量任何另外的造影剂进入所述目标区域或修改的造影剂在所述目标区域之外的流速。

    AUTOMATED MONITORING OF MYOCARDIAL FUNCTION BY ULTRASONIC TRANSDUCERS POSITIONED ON THE HEART
    6.
    发明申请
    AUTOMATED MONITORING OF MYOCARDIAL FUNCTION BY ULTRASONIC TRANSDUCERS POSITIONED ON THE HEART 审中-公开
    通过位于心脏上的超声波传感器自动监测心肌功能

    公开(公告)号:US20110046488A1

    公开(公告)日:2011-02-24

    申请号:US12672569

    申请日:2008-08-29

    IPC分类号: A61B8/00

    摘要: The invention relates to a method and a post-operative care unit for analysing and quantifying an ultrasound tissue Doppler imaging (TDI) signal from a transducer fastened on the myocardium to obtain a parameter indicating regional cardiac ischaemia or correlates with global hypokinetic heart function. This has the advantage over manually operated probes that it can be automated and used continuously over long time. According to the method, a TDI signal trace corresponding to at least one of tissue velocity, strain or strain rate is extracted and correlated with an electrocardiogram to define subsections within a cardiac cycle in the extracted trace corresponding to the early systolic phase and the post-systolic phase. Then, a velocity, strain or strain rate is read in at least the post-systolic phase of the extracted trace, and a parameter which is a function of one of these readings and which indicates ischaemia or global hypokinetic function is generated.

    摘要翻译: 本发明涉及一种用于分析和量化来自紧固在心肌上的传感器的超声组织多普勒成像(TDI)信号以获得指示区域性心脏缺血或与全身低动力心脏功能相关的参数的方法和术后护理单元。 这具有超过手动操作的探头的优点,可以自动化并长时间连续使用。 根据该方法,提取对应于组织速度,应变或应变速率中的至少一个的TDI信号迹线,并将其与心电图相关联,以在对应于早期收缩期和后期收缩期的提取迹线中定义心脏周期内的子部分, 收缩期。 然后,至少在提取的迹线的收缩期后读取速度,应变或应变速率,并且产生作为这些读数中的一个的函数并且表示缺血或全身低动力学功能的参数。